Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

421.67 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 72
Open 421.67
Bid (Size) 415.00 (120)
Ask (Size) 431.50 (40)
Prev. Close 421.67
Today's Range 421.67 - 421.67
52wk Range 362.50 - 519.88
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday?
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date... 
Via Benzinga
VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11% year on year to $3.08 billion. The company’s outlook for the full year was... 
Via StockStory

Performance

YTD
+3.9%
+3.9%
1 Month
+4.7%
+4.7%
3 Month
+12.5%
+12.5%
6 Month
-6.3%
-6.3%
1 Year
-10.8%
-10.8%

More News

Read More
Earnings Scheduled For November 3, 2025
Via Benzinga
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Q3 In Line With Expectations
Via StockStory
Vertex Pharma Dips Despite Quarterly Beat And Slight Guidance Book
Via Investor's Business Daily
Vertex Reports Third Quarter 2025 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday?
Via Benzinga
2 Healthcare Stocks for Individual Investors With a 20-Year Time Horizon
Via The Motley Fool
Topics Intellectual Property
Inflation-Proof Investing: Which Growth Stock Will Double Your Money in 6 Years?
Via The Motley Fool
Topics Economy Government World Trade
My Top Growth Stock to Buy in November
Via The Motley Fool
Vertex Pharmaceuticals (VRTX) Q3 Earnings: What To Expect
Via StockStory
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks
Via MarketBeat
Here's How Much $100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth Today
Via Benzinga
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Fundamentals and Bullish Technical Setup
Via Chartmill
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
Via The Motley Fool
Vertex to Participate in the UBS Global Healthcare Conference on November 11
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Prediction: Vertex Pharmaceuticals Will Be Worth More Than Pfizer by 2030
Via The Motley Fool
Topics Intellectual Property
The Best Stocks to Invest $50,000 In Right Now
Via The Motley Fool
Topics Artificial Intelligence Energy
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A Value Investment Case Study
Via Chartmill
2 Growth Stocks to Invest $1,000 in Right Now
Via The Motley Fool
Topics Artificial Intelligence World Trade
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
From Vertex Pharmaceuticals Incorporated
Via Business Wire
2 Soaring Cathie Wood Stocks to Buy and Hold
Via The Motley Fool
Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market
Via Benzinga

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 421.67
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 11/04/25 04:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 109.39B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 109B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.